Your browser doesn't support javascript.
loading
Successful Treatment of Relapsed Acquired Amegakaryocytic Thrombocytopenia with Repeat Cyclosporine / 대한내과학회지
Korean Journal of Medicine ; : 258-261, 2016.
Article in English | WPRIM | ID: wpr-36016
ABSTRACT
Acquired amegakaryocytic thrombocytopenia (AAMT) is an unusual disease characterized by severe thrombocytopenia resulting from a marked decrease in bone marrow megakaryocytes. Various pathogenic mechanisms have been suggested, and several treatments have been tried, with varying outcomes. In some case reports, cyclosporine and anti-thymocyte globulin have had good clinical results in the treat of AAMT. There are few reports on the treatment of relapsed AAMT with cyclosporine. We report a patient with relapsed AAMT who was treated successfully with an additional course of cyclosporine. The initial remission was achieved with cyclosporine 4 years earlier and a second remission was induced by cyclosporine. Cyclosporine may be effective for relapsed AAMT that previously responded to cyclosporine.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Thrombocytopenia / Bone Marrow / Megakaryocytes / Cyclosporine / Antilymphocyte Serum Limits: Humans Language: English Journal: Korean Journal of Medicine Year: 2016 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Thrombocytopenia / Bone Marrow / Megakaryocytes / Cyclosporine / Antilymphocyte Serum Limits: Humans Language: English Journal: Korean Journal of Medicine Year: 2016 Type: Article